Scale-up/Technology Transfer

Tevogen Completes Tech Transfer to CDMO BioCentriq

Reaches commercial manufacturing readiness milestone for its investigational COVID-19 therapy TVGN-489.

09.16.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Lonza, Sheba Medical Center Leverage Cocoon Platform for Cell Therapy

Customizable, patient-scale cell therapy platform aims to streamline manufacturing to improve process efficiency and reliability.

08.12.21

CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers

Aphena is a service provider in the pharmaceutical, OTC, medical device, biologics and personal care industries.

Sponsored released by Aphena Pharma Solutions 08.10.21

cGMP Manufacture | Formulation Development | Scale-up/Technology Transfer

Solving Solubility Challenges for a Novel Oncology Drug

Learn how Lubrizol Life Science Health solved bioavailability challenges and scaled a commercially viable formulation of a new cancer treatment.

Sponsored released by Lubrizol Life Science Health 08.03.21

Drug Development | Scale-up/Technology Transfer | Validation

Keys to Successful Tech Transfer for Topical Pharmaceuticals

This whitepaper illustrates the keys to choosing the right manufacturing partner and how to manage a topical drug tech transfer.

Moderna, Samsung Biologics Ink COVID Vax Mfg. and Supply Pact

Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273 from its facilities in Incheon, South Korea.

Kristin Brooks 05.24.21

Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Asher Bio, ProBioGen Ink Development, Mfg. Agreement

ProBioGen to provide cell line development, process development and GMP manufacturing at 1000 L bioreactor scale of Asher's lead immuno-oncology candidate.

Kristin Brooks 04.26.21

Aseptic Processing | Fill/Finish | Parenterals | Process Development | Scale-up/Technology Transfer

Vetter Commercial Manufacturing

Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

CureVac, Celonic Enter COVID-19 Vax Mfg. Pact

Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.

Kristin Brooks 03.30.21

cGMP Manufacture | Drug Development | Scale-up/Technology Transfer

Fast Track Automation in Pharmaceutical Manufacturing

Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and risk

Steve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 03.25.21

Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer

Plus Therapeutics, Piramal Ink Master Services Agreement

Development, manufacturing and supply deal is for Plus’ Rhenium NanoLiposome intermediate drug product.

Tim Wright, Editor, Contract Pharma 03.23.21

Biologics, Proteins, Vaccines | Breaking News | Industry News | Scale-up/Technology Transfer

SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax

Will leverage SUREtechnology Platform to generate stable, high-yield production cell lines needed for human clinical trials.

Kristin Brooks 03.18.21

cGMP Manufacture | Process Development | Scale-up/Technology Transfer

Process Intensification: Understanding the Optimal Way to Maximize Productivity

Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.

Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21

Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer